Evidence map›Paper›PMID 42225260›Full record

ArticleBioconjugate chemistry2026

Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery Platform.

Amy E Laturski, Verónica Durán, Bruce T Schaar, Maria T Dulay, Shirit Einav, Joseph M DeSimone

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioconjugate chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amy E LaturskiDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Verónica DuránDepartment of Medicine and Department of Microbiology and Immunology, Stanford University, Stanford, California 94305, United States.
Bruce T SchaarCanary Center at Stanford for Cancer Early Detection, Department of Radiology, School of Medicine, Stanford University, Stanford, California 94305, United States.
Maria T DulayDepartment of Radiology, Stanford University, Stanford, California 94305, United States.ORCID 0000-0002-4678-3480
Shirit EinavDepartment of Medicine and Department of Microbiology and Immunology, Stanford University, Stanford, California 94305, United States.ORCID 0000-0001-6441-4171
Joseph M DeSimoneCanary Center at Stanford for Cancer Early Detection, Department of Radiology, School of Medicine, Stanford University, Stanford, California 94305, United States.ORCID 0000-0001-9521-5095

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current mRNA-based vaccine platforms are limited by complex fabrication, stringent cold-chain dependence, and off-target

Indexed as

Dendritic CellsDrug Delivery SystemsNanogelsRNA, MessengerAnimalsHEK293 CellsHumansMiceMice, Inbred BALB CPolyethyleneimineNanogelsPolyethyleneimineRNA, Messenger

Identifiers

PMID42225260
PMCPMC13281390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.